Stock Earnings

Question 1

What are Adaptive Biotechnologies Corp's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Adaptive Biotechnologies Corp has a total asset of $512, Net loss of $-59

Question 2

What are the key financial ratios for ADPT?

Accepted Answer

Adaptive Biotechnologies Corp's Current ratio is 1.74, has a Net margin is -21.37, sales per share of $1.81.

Question 3

How is Adaptive Biotechnologies Corp's revenue broken down by segment or geography?

Accepted Answer

Adaptive Biotechnologies Corp largest revenue segment is Minimal Residual Disease - Service, at a revenue of 192,834,000 in the most earnings release.For geography, United States is the primary market for Adaptive Biotechnologies Corp, at a revenue of 276,976,000.

Question 4

Is Adaptive Biotechnologies Corp profitable?

Accepted Answer

no, according to the latest financial statements, Adaptive Biotechnologies Corp has a net loss of $-59

Question 5

Does Adaptive Biotechnologies Corp have any liabilities?

Accepted Answer

yes, Adaptive Biotechnologies Corp has liability of 293

Question 6

How many outstanding shares for Adaptive Biotechnologies Corp?

Accepted Answer

Adaptive Biotechnologies Corp has a total outstanding shares of 153.77

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	295	276	178	170	185	154
Revenue Growth (YoY)	56%	55%	5%	-8%	20%	56.99%
Cost of Revenue	73	71	72	75	57	49
Gross Profit	222	205	106	94	127	105
Selling, General & Admin	174	167	157	172	183	170
Research & Development	84	83	94	109	122	142
Operating Expenses	269	262	262	296	326	314
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-49	-59	-159	-225	-200	-207
Income Tax Expense	--	0	--	--	--	--
Net Income	-49	-59	-159	-225	-200	-207
Net Income Growth	-65%	-63%	-28.99%	13%	-3%	42%
Shares Outstanding (Diluted)	155.52	151.72	147.1	144.38	142.5	140.4
Shares Change (YoY)	4%	3%	2%	1%	2%	7%
EPS (Diluted)	-0.32	-0.39	-1.08	-1.56	-1.4	-1.48
EPS Growth	-66%	-64%	-31%	11%	-5%	33%
Free Cash Flow	-29	-48	-98	-167	-200	-254
Free Cash Flow Per Share	-0.18	-0.31	-0.66	-1.15	-1.4	-1.8
Gross Margin	75.25%	74.27%	59.55%	55.29%	68.64%	68.18%
Operating Margin	-15.59%	-20.65%	-87.07%	-118.23%	-107.02%	-135.71%
Profit Margin	-16.61%	-21.37%	-89.32%	-132.35%	-108.1%	-134.41%
Free Cash Flow Margin	-9.83%	-17.39%	-55.05%	-98.23%	-108.1%	-164.93%
EBITDA	-30	-46	-145	-187	-178	-208
EBITDA Margin	-10.16%	-16.66%	-81.46%	-110%	-96.21%	-135.06%
D&A For EBITDA	16	11	10	14	20	1
EBIT	-46	-57	-155	-201	-198	-209
EBIT Margin	-15.59%	-20.65%	-87.07%	-118.23%	-107.02%	-135.71%
Effective Tax Rate	--	0%	--	--	--	--

Adaptive Biotechnologies Corp (ADPT) Price

ADPT Stock Price Chart

ADPT Income

Follow-Up Questions